Alkermes ALKS
NASDAQ ALKS
$40.54 +0.02 (+0.05%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alkermes (ALKS) Consolidated Net Income (2010 - 2026)

Updated

Alkermes' Consolidated Net Income came in at $524,000 for Q2 2026, down 99.4% from $87.1 million a year earlier.

Analysis

Alkermes (ALKS) Consolidated Net Income (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alkermes reported Consolidated Net Income of $66.1 million, down 81.0% year-over-year; for FY2025, it was $241.66 million, down 34.2% from FY2024.

  • Going back by year, Consolidated Net Income was $367.07 million in FY2024 (+3.2%), $355.76 million in FY2023, -$158.27 million in FY2022 and -$48.17 million in FY2021.
  • The five-year range for quarterly Consolidated Net Income is -$66.53 million (Q1 2026) to $237.07 million (Q2 2023).
  • Year-over-year, Consolidated Net Income increased in two of the last seven quarters, with an average decline of 13.8%.
  • The fastest year-over-year change in Consolidated Net Income over five years came in Q3 2024 (growth of 93.4%), and the weakest in Q2 2026 (a decline of 99.4%).
  • Business Quant data shows ALKS's Consolidated Net Income at -$66.53 million (Q1 2026), $49.34 million (Q4 2025) and $82.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.51 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Alkermes 6.79 Bn 3.92 Bn 397.90 Mn 524,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 524,000.00
Mar 31, 2026 -66.53 Mn
Dec 31, 2025 49.34 Mn
Sep 30, 2025 82.76 Mn
Jun 30, 2025 87.10 Mn
Mar 31, 2025 22.46 Mn
Dec 31, 2024 146.50 Mn
Sep 30, 2024 92.38 Mn
Jun 30, 2024 91.36 Mn
Mar 31, 2024 36.83 Mn
Dec 31, 2023 112.78 Mn
Sep 30, 2023 47.76 Mn
Jun 30, 2023 237.07 Mn
Mar 31, 2023 -41.85 Mn
Dec 31, 2022 96.86 Mn
Sep 30, 2022 -63.97 Mn
Jun 30, 2022 -30.14 Mn
Mar 31, 2022 -35.90 Mn
Dec 31, 2021 125.44 Mn
Sep 30, 2021 -28.99 Mn
API Access

Alkermes Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY